AgomAb Therapeutics NV (AGMB)
9.18
+0.38
(+4.32%)
USD |
NASDAQ |
Oct 08, 16:00
9.18
0.00 (0.00%)
After-Hours: 16:46
AgomAb Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 2.790 |
| October 06, 2026 | 2.802 |
| October 05, 2026 | 2.755 |
| October 02, 2026 | 2.714 |
| October 01, 2026 | 2.742 |
| September 30, 2026 | 3.519 |
| September 29, 2026 | 3.338 |
| September 28, 2026 | 3.237 |
| September 25, 2026 | 3.332 |
| September 24, 2026 | 3.354 |
| September 23, 2026 | 3.413 |
| September 22, 2026 | 3.642 |
| September 21, 2026 | 3.709 |
| September 18, 2026 | 3.858 |
| September 17, 2026 | 3.830 |
| September 16, 2026 | 3.617 |
| September 15, 2026 | 3.855 |
| September 14, 2026 | 3.893 |
| September 11, 2026 | 4.140 |
| September 10, 2026 | 4.419 |
| September 09, 2026 | 4.742 |
| September 08, 2026 | 4.727 |
| September 04, 2026 | 5.002 |
| September 03, 2026 | 4.701 |
| September 02, 2026 | 4.330 |
| Date | Value |
|---|---|
| September 01, 2026 | 4.292 |
| August 31, 2026 | 4.175 |
| August 28, 2026 | 4.175 |
| August 27, 2026 | 4.388 |
| August 26, 2026 | 4.527 |
| August 25, 2026 | 4.444 |
| August 24, 2026 | 4.064 |
| August 21, 2026 | 4.200 |
| August 20, 2026 | 4.258 |
| August 19, 2026 | 4.359 |
| August 18, 2026 | 4.353 |
| August 17, 2026 | 4.337 |
| August 14, 2026 | 4.191 |
| August 13, 2026 | 4.421 |
| August 12, 2026 | 4.473 |
| August 11, 2026 | 4.708 |
| August 10, 2026 | 4.755 |
| August 07, 2026 | 4.597 |
| August 06, 2026 | 4.280 |
| August 05, 2026 | 4.540 |
| August 04, 2026 | 4.670 |
| August 03, 2026 | 4.286 |
| July 31, 2026 | 4.08 |
| July 30, 2026 | 4.044 |
| July 29, 2026 | 3.931 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 14.00 |
| CNBX Pharmaceuticals, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | 0.8728 |
| Fulcrum Therapeutics, Inc. | 0.9220 |
Price to Book Value Related Metrics
| Price | 9.18 |
| Market Cap | 452.10M |